Osaic Holdings
LKFT

Osaic Holdings’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Osaic Holdings’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.5K Buy
483
+113
+31% +$3.74K ﹤0.01% 6066
2025
Q4 		$12.1K Sell
370
-255
-41% -$8.23K ﹤0.01% 6219
2025
Q3 		$21.5K Buy
625
+278
+80% +$8.89K ﹤0.01% 5882
2025
Q2 		$9.68K Buy
347
+60
+21% +$1.61K ﹤0.01% 6170
2025
Q1 		$7.21K Sell
287
-97
-25% -$2.45K ﹤0.01% 5966
2024
Q4 		$10.6K Buy
384
+30
+8% +$836 ﹤0.01% 5769
2024
Q3 		$10.2K Buy
354
+134
+61% +$3.65K ﹤0.01% 5805
2024
Q2 		$5.45K Buy
220
+139
+172% +$3.94K ﹤0.01% 6121
2024
Q1 		$2.61K Buy
81
+43
+113% +$1.6K ﹤0.01% 6369
2023
Q4 		$1.54K Sell
38
-1,384
-97% -$50.9K ﹤0.01% 6626
2023
Q3 		$49.1K Buy
1,422
+695
+96% +$27.1K ﹤0.01% 5018
2023
Q2 		$29.6K Sell
727
-86
-11% -$3.51K ﹤0.01% 5299
2023
Q1 		$31.4K Hold
813
– – ﹤0.01% 5289
2022
Q4 		$36K Hold
813
– – ﹤0.01% 5169
2022
Q3 		$34K Buy
813
+5
+0.6% +$256 ﹤0.01% 5203
2022
Q2 		$45K Sell
808
-12
-1% -$711 ﹤0.01% 5037
2022
Q1 		$52K Sell
820
-406
-33% -$24.9K ﹤0.01% 5064
2021
Q4 		$68K Buy
1,226
+467
+62% +$24.4K ﹤0.01% 4902
2021
Q3 		$40K Sell
759
-2,888
-79% -$171K ﹤0.01% 5267
2021
Q2 		$251K Sell
3,647
-812
-18% -$61.9K ﹤0.01% 3677
2021
Q1 		$344K Buy
4,459
+284
+7% +$26.2K ﹤0.01% 3256
2020
Q4 		$413K Buy
4,175
+1,195
+40% +$146K ﹤0.01% 2830
2020
Q3 		$423K Sell
2,980
-527
-15% -$87.9K ﹤0.01% 2583
2020
Q2 		$692K Sell
3,507
-158
-4% -$32.7K ﹤0.01% 2060
2020
Q1 		$718K Buy
+3,665
New +$789K ﹤0.01% 1785

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings's LKFT Position: Q1 2026 in Review

Osaic Holdings increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 31% in Q1 2026, buying an estimated $3.74K and bringing the position to 483 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6066.

Osaic Holdings first reported a position in LKFT in Q1 2020 and has held it in 25 quarters since. The position peaked at $718K in Q1 2020. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Osaic Holdings held 483 shares of Lakefront Biotherapeutics American Depositary Shares worth $14.5K as of Q1 2026.
  • Osaic Holdings bought 113 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $3.74K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6066 holding.
  • Osaic Holdings first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Lakefront Biotherapeutics American Depositary Shares position peaked at $718K in Q1 2020.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.